Ali, M., Ratain, M. J. (2026). Potential alternative dosing strategies for FDA-approved oncology biologics based on reanalysis of exposure-response data.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15135